BioTech Social Media and Updates

AI Models Map Worm Brain, Scale to Synthetic Biology
SocialApr 15, 2026

AI Models Map Worm Brain, Scale to Synthetic Biology

The C. elegans nervous system has exactly 302 neurons and 7,000 synaptic connections. Scientists have had the full wiring diagram since 1986. What they haven't had: a computational model that captures how those neurons actually develop and wire themselves up. Eric Wasiolek...

By John Cumbers
Grapefruit Compound Bergamottin Blocks STAT3, Triggers Tumor Cell Death
SocialApr 14, 2026

Grapefruit Compound Bergamottin Blocks STAT3, Triggers Tumor Cell Death

Bergamottin, a natural furanocoumarin obtained from grapefruit juice induces chemosensitization and apoptosis through the inhibition of STAT3 signaling pathway in tumor cells https://t.co/cLRxHMFBCJ

By Michael Lustgarten, PhD
One Injection Restores Hearing via OTOF Gene Therapy
SocialApr 14, 2026

One Injection Restores Hearing via OTOF Gene Therapy

A single injection uses an engineered AAV virus to deliver a healthy OTOF gene into cochlear cells, enabling them to produce otoferlin and restore the ear’s ability to convert sound vibrations into signals the brain can interpret. https://t.co/Lk34jpnRBe

By Liz Parrish
FDA's 27-Year Freeze Stalled Critical Strep A Vaccine
SocialApr 14, 2026

FDA's 27-Year Freeze Stalled Critical Strep A Vaccine

The FDA accidentally froze Strep A vaccine development for 27 years. @AsimovPress explains what happened and where things stand now, ft. @jacobtrefethen and @coeff_giving's research.

By Alexander Berger
RNA‑seq No Longer a Bottleneck: 3‑day Turnaround
SocialApr 14, 2026

RNA‑seq No Longer a Bottleneck: 3‑day Turnaround

What if sequencing wasn’t the bottleneck anymore? #SynBioBeta2026 is May 4-7th in San Jose, California, you can learn more about the conference and get your tickets here: https://t.co/8abYWJ18mc @plasmidsaurus is removing friction from RNA-seq. 3-day turnaround in Europe. No dry ice. This is...

By John Cumbers
Physics‑Based Sensors and AI Transform Bioreactor Monitoring
SocialApr 14, 2026

Physics‑Based Sensors and AI Transform Bioreactor Monitoring

Bioreactors are billion-dollar processes monitored by pH probes and dissolved oxygen sensors. That's like running a semiconductor fab with a thermometer. @schmidtsciences is adapting physics tools that don't usually touch biology: fluorescent nanodiamonds, single-cell Raman spectroscopy, and optical frequency combs that...

By John Cumbers
High Blood Glucose Linked to Cognitive Decline via Lactate Pathway
SocialApr 14, 2026

High Blood Glucose Linked to Cognitive Decline via Lactate Pathway

How do high glucose levels in the blood impair cognition and predict mild cognitive impairment in people with diabetes? @scisignal Elevated plasma lactate and related pathway, with a peptide intervention to potentially address it https://t.co/ai1369HWVU https://t.co/JcszZT2Tt2

By Eric Topol
Targeting Aging: Epigenetic Reprogramming Tackles Disease Root
SocialApr 14, 2026

Targeting Aging: Epigenetic Reprogramming Tackles Disease Root

Aging is arguably the root cause of most major diseases. Our cells lose function as we age, allowing various conditions to manifest, which is why most major diseases correlate with age. Yes, it is more complex than this, but this is...

By Brian Armstrong
Low‑cost Vaccines Bypass Big Pharma, Influencers Profit
SocialApr 14, 2026

Low‑cost Vaccines Bypass Big Pharma, Influencers Profit

No, the opposite. I develop low cost vaccines that bypass big pharma. The only shills are those connected to the corrupt wellness influencer industry, which buys whatever it can in bulk cheap so they can jack up the price with...

By Peter Hotez
Nasal EV Spray Reverses Neuroinflammation and Boosts Memory
SocialApr 14, 2026

Nasal EV Spray Reverses Neuroinflammation and Boosts Memory

A nasal spray delivering extracellular vesicles reversed neuroinflammation, restored mitochondrial function, and improved memory in aging brain models, suggesting a noninvasive approach to counteract cognitive decline. neuroscience

By Phys.org Threads
MIC11 Deletion Traps Parasites, Reveals Escape Target
SocialApr 14, 2026

MIC11 Deletion Traps Parasites, Reveals Escape Target

Removal of the MIC11 gene traps parasites inside host cells by blocking membrane rupture, highlighting a critical mechanism required for their escape and suggesting a potential target for controlling parasite-borne diseases. parasitology

By Phys.org Threads
Genetically Switched Microbes Aim to Cut Synthetic Nitrogen Use
SocialApr 14, 2026

Genetically Switched Microbes Aim to Cut Synthetic Nitrogen Use

Nitrogen fertilizer feeds 4 billion people. It also uses 2% of global energy to produce and loses nearly half of what's applied to runoff. Biology has promised a fix for decades. The problem: engineered microbes that make nitrogen can't also compete...

By John Cumbers
GLP‑1 Drugs Show Weight‑loss‑independent Benefits, Study Finds
SocialApr 14, 2026

GLP‑1 Drugs Show Weight‑loss‑independent Benefits, Study Finds

Great work by @DanielJDrucker and team; biologically plausible mechanism of GLP1-RA benefit independent of weight loss. Excellent article by @megtirrell @CNN describing the publication. Could it justify new approaches for these drugs? I think so. https://t.co/pHudk7lkAR

By Harlan Krumholz
Breast Milk’s Living Stem Cells May Reach Infant Brain
SocialApr 14, 2026

Breast Milk’s Living Stem Cells May Reach Infant Brain

Breast milk contains living stem cells. In animal studies, these cells survived digestion in newborns, entered the bloodstream, and were found in multiple tissues including the brain. Whether this happens in humans is still being studied, but the animal data...

By Preethi Kasireddy
Bots Code My Tools While I Hit the Wetlab
SocialApr 14, 2026

Bots Code My Tools While I Hit the Wetlab

Launching bots to code my science tools while I go do wetlab work feels like this track: https://t.co/xxRAzKXQ4x

By Sebastian Cocioba
Comprehensive Genomic Panel Broadens Oncology Treatment Options
SocialApr 14, 2026

Comprehensive Genomic Panel Broadens Oncology Treatment Options

Unique Features of a Comprehensive Genomic Profiling Panel: Expanding Treatment Options in a Value-Based Community Oncology Network [Mar 9, 2026] La Porte et al. @DrEzraCohen @JCOPO_ASCO https://t.co/tDi3kbxdvX #PrecisionMedicine #hemeonc @TempusAI https://t.co/zgEw8hfFia

By Mike Thompson, MD PhD
Real-World Data Reveal Molecular Profile of Metastatic ILC
SocialApr 14, 2026

Real-World Data Reveal Molecular Profile of Metastatic ILC

Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/oDkC1Ua6DS

By Mike Thompson, MD PhD
PurIST Classifier Validated for Pancreatic Cancer Therapy
SocialApr 14, 2026

PurIST Classifier Validated for Pancreatic Cancer Therapy

Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection [PurIST @TempusAI] in Pancreatic Ductal Adenocarcinoma [Sep 4, 2025] @stephwen et al. @JCOPO_ASCO https://t.co/R24DErvaB4 #pancsm #PrecisionMedicine https://t.co/40LqNDQJHo

By Mike Thompson, MD PhD
Somatic Immune Cell Mutations Linked to Autoimmunity
SocialApr 14, 2026

Somatic Immune Cell Mutations Linked to Autoimmunity

New evidence that somatic mutations in immune cells can be the basis for autoimmune disease @Nature https://t.co/GvzxLYgvfw

By Eric Topol
RUNX1 Identified as Key to Rejuvenate Aging T Cells
SocialApr 14, 2026

RUNX1 Identified as Key to Rejuvenate Aging T Cells

Discovery of a factor (RUNX1) that pinpoints T cell senescence and restoring its functionality achieves T cell rejuvenation. Significant implications in older adults with loss of immune system protection. https://t.co/X58DvzIUXY @ImmunityCP https://t.co/hzL3zFiPMm

By Eric Topol
Continuous Fermentation Cuts Costs, Beats Traditional Bioreactors
SocialApr 14, 2026

Continuous Fermentation Cuts Costs, Beats Traditional Bioreactors

The biomanufacturing bottleneck isn't biology. It's economics. Building bigger bioreactors doesn't fix unit costs. https://t.co/2RAcw704uk's bet: continuous fermentation decouples growth from production, keeps cells in an ultra-productive state for weeks, and runs like a conveyor belt instead of a batch process. ...

By John Cumbers
GLP‑1 Receptors Protect Liver in Mouse MASH Model
SocialApr 14, 2026

GLP‑1 Receptors Protect Liver in Mouse MASH Model

Adding to the GLP-1 drug weight-loss independent effect benefit : impact on liver sinusoidal endothelial cell GLP-1 receptors for liver protection in mouse MASH model @Cell_Metabolism @DanielJDrucker @ChusaGzlzRellan https://t.co/0A13QYgm05

By Eric Topol
Command-Line Genome Viewers: Terminal Genome Viewer & ASCIIGenome
SocialApr 14, 2026

Command-Line Genome Viewers: Terminal Genome Viewer & ASCIIGenome

Terminal Genome Viewer https://t.co/ppe3ckC5kp Another one that is around for a while: ASCIIGenome https://t.co/pnrzu48qZo https://t.co/qRCjn2Rft2

By Ming Tang
Age Spots Linked to Epigenetic Drift, Potentially Reversible
SocialApr 14, 2026

Age Spots Linked to Epigenetic Drift, Potentially Reversible

Could age spots be due to a suspected cause of aging? New paper says: "Consistent with the Information Theory of Aging, we found a global disruption of tight epigenetic regulation of methylation states." If so, they are reversible. Can't wait to...

By David Sinclair
Low P‑tau217 Indicates Minimal Alzheimer’s Risk in Seniors
SocialApr 14, 2026

Low P‑tau217 Indicates Minimal Alzheimer’s Risk in Seniors

Another study indicative of predictive power of p-tau217 for Alzheimer's disease in cognitively unimpaired older adults (mean age 71 at baseline) A very low p-tau217 denoted minimal risk https://t.co/6RPJcCloWI https://t.co/XikzsvJjhM

By Eric Topol
In‑vivo Base Editing Rescues Zellweger Disorder in Mice
SocialApr 14, 2026

In‑vivo Base Editing Rescues Zellweger Disorder in Mice

Today in @natBME we report an in vivo base editing strategy that corrects a common disease-causing mutation and rescues pathology in a mouse model of Zellweger spectrum disorder (ZSD) and restore peroxisomal function in patient derived cells. This work highlights...

By David Liu
AI‑designed Sensors Promise Earlier Cancer Detection
SocialApr 14, 2026

AI‑designed Sensors Promise Earlier Cancer Detection

As a medical school professor, I can tell you: we catch most cancers too late. MIT and Microsoft may have just changed that forever. They built an AI system called CleaveNet that designs molecular sensors detecting cancer enzymes called proteases --...

By Robert Lufkin, MD
SGO Numbers: Some Winners, Many Disappointments Await
SocialApr 14, 2026

SGO Numbers: Some Winners, Many Disappointments Await

Lots of gaudy headline numbers coming out of SGO this year; do they stack up under scrutiny? My take – some winners likely and many tears before bedtime for others. Which ones fall in the latter category? ...

By Sally Church
Government Support Can Unlock Life Sciences Job Growth
SocialApr 14, 2026

Government Support Can Unlock Life Sciences Job Growth

Having worked in the Science Park sector for 20 years Life Sciences is a sector where some government support will make a massive difference to job and wealth creation

By Bob Cushing
Anavex Shows Promise, but EMA Hurdles Loom
SocialApr 14, 2026

Anavex Shows Promise, but EMA Hurdles Loom

Macro: autophagy links autism & Alzheimer’s. Key: Anavex blarcamesine restores autophagy; positive Phase IIb/III data. Risk: EMA pushback. Insight: speculative long, tight stop. 🔬 — Viktor Kopylov, PhD, CFA More insights: t.me/si14Kopylov

By Viktor Kopylov, PhD, CFA
TVTX Surges 45% After FDA Approval, Long Calls Lead
SocialApr 14, 2026

TVTX Surges 45% After FDA Approval, Long Calls Lead

$TVTX jumps 45% on FDA approval, always liked this one, continues to work 5K Apr. 32.5 long calls leads the way https://t.co/g7Ga8FIJve

By Joe Kunkle
Scientists Urge Continuous Monitoring for Emergent Consciousness in Organoids
SocialApr 14, 2026

Scientists Urge Continuous Monitoring for Emergent Consciousness in Organoids

"Perhaps most crucially for this field is the concern that emergent properties, such as consciousness, might arise in complex organoids. So far, there has been no evidence that any form of sentience could emerge, but researchers would like this to...

By Sebastian Cocioba
SGLT2 Inhibitors Protect Kidneys, Yet Raise Non‑Renal Risks
SocialApr 14, 2026

SGLT2 Inhibitors Protect Kidneys, Yet Raise Non‑Renal Risks

Sodium-Glucose Cotransporter-2 Inhibitors and Acute Kidney Injury Risk: A Systematic Review and Meta-Analysis of Randomized Trials "SGLT2is conferred substantial renoprotective benefits but increases the risk of certain nonrenal AEs." https://t.co/n0yhZgcShy

By David Barzilai, MD PhD
Alzheimer's May Be Multifactorial End‑Stage, Not Single Cause
SocialApr 14, 2026

Alzheimer's May Be Multifactorial End‑Stage, Not Single Cause

Absolutely astounding that two of the most interesting candidates for lowering Alzheimer’s risk in the last decade came accidentally: GLP-1 drugs and the shingles vaccine. Really suggests Alzheimer’s has no true “cause”, but is the end stage of a long, complex...

By Hank Green
Navy SEAL and Doctor Discuss Stem Cell Breakthroughs
SocialApr 14, 2026

Navy SEAL and Doctor Discuss Stem Cell Breakthroughs

Great podcast with my good friend and Navy Seal William Clark and Dr. Harmon on Stem Cells https://t.co/BDKfPiMHnF

By Charles Hoskinson
Crossing the SynBio Valley of Death with Proven Solutions
SocialApr 14, 2026

Crossing the SynBio Valley of Death with Proven Solutions

Most synbio companies die between "works in the lab" and "works at scale." Freedom-to-operate issues, process robustness, CMC readiness. The valley of death is real and it swallows good science. @IngenzaLtd has been helping teams cross it for 20 years. Leonardo Magneschi...

By John Cumbers
Proline‑mediated Dichloromethyl Tagging Enables Ultra‑pure Drug Synthesis
SocialApr 13, 2026

Proline‑mediated Dichloromethyl Tagging Enables Ultra‑pure Drug Synthesis

A new method uses the amino acid proline to precisely attach dichloromethyl groups to complex molecules, enabling ultra-pure drug synthesis with built-in quality control and expanding possibilities for advanced medicine design. drugdiscovery

By Phys.org Threads
Serum Proteomics Distinguishes Endurance versus Strength Adaptations
SocialApr 13, 2026

Serum Proteomics Distinguishes Endurance versus Strength Adaptations

Adaptations to endurance vs strength training in elite athletes revealed by serum proteomics https://t.co/ii3xAiNEcT https://t.co/hBfQ0E0v9W

By David Barzilai, MD PhD
Why Anthropic Chose Coefficient Bio Over Bigger Rivals?
SocialApr 13, 2026

Why Anthropic Chose Coefficient Bio Over Bigger Rivals?

Reading up on the Coefficient Bio deal. I totally get the industrial logic around why Anthropic should care about drug discovery. But why this particular company? There's lots of more scaled players doing this. Can anyone educate me? https://t.co/akFVmRUaYw

By Christina Farr
DeepSeqAI Trains on Function to Future‑proof Biologics
SocialApr 13, 2026

DeepSeqAI Trains on Function to Future‑proof Biologics

Most AI protein tools are trained on structure. DeepSeqAI trains on function. They're running billions of experimental protein-protein interactions through their platform to map biologics against viruses, immune receptors, and the entire human proteome. The goal: candidates that hold up against...

By John Cumbers
CRISPR Turns 25: Explore Its Past, Present, Future
SocialApr 13, 2026

CRISPR Turns 25: Explore Its Past, Present, Future

Introducing the GEN Keynote Webinar: "CRISPR at 25: The Past, Present, and Future of Genome Editing" Guest speaker: Rodolphe Barrangou @CRISPRchef May 4, 2026: noon ET/9 am PT Sponsored by @elevatebio https://t.co/cYsSsaod4Y via @GENbio

By Kevin Davies
Busy Biotech Day Highlights Promising Advances and Insightful Commentary
SocialApr 13, 2026

Busy Biotech Day Highlights Promising Advances and Insightful Commentary

As usual, excellent summary by @ldtimmerman @timmermanreport of busy and promising biotech news day - as always delivered w insight and heart (especially thoughtful comments re: revmed drug in context of poignant recent @BenSasse interview)

By David Shaywitz, MD, PhD
FDA Zeroes in on Houman Hemmati for CBER Lead
SocialApr 13, 2026

FDA Zeroes in on Houman Hemmati for CBER Lead

FDA narrows in on search for new biologics and vaccines leader - and we’re hearing @houmanhemmati is a top contender for CBER - https://t.co/qMx8wv32fG

By Zach Brennan
Robust Bio Tools Demand Exhaustive Edge‑Case Testing
SocialApr 13, 2026

Robust Bio Tools Demand Exhaustive Edge‑Case Testing

Hardest part of making bio tools is the endless testing of edge cases, to make sure that sequences are holy, circular permutation is accounted for, degenerate bases are considered, etc. To make robust code worthy of wetlab requires attention. I'm...

By Sebastian Cocioba
Off‑the‑Shelf CAR‑T Shows Promise Delaying Lymphoma Relapse
SocialApr 13, 2026

Off‑the‑Shelf CAR‑T Shows Promise Delaying Lymphoma Relapse

Allogene data suggest ‘off-the-shelf’ CAR-T could delay relapse in lymphoma https://t.co/UrSNYpQFqB by @gwendolynawu $ALLO + 25%

By Ben Fidler
Pancreatic Cancer Drug Nearly Doubles Survival in Trial
SocialApr 13, 2026

Pancreatic Cancer Drug Nearly Doubles Survival in Trial

Revolution pancreatic cancer drug nearly doubles survival in key trial https://t.co/SvJicU0LIz @ByJonGardner $RVMD + 38%

By Ben Fidler
Revolution Medicines' Pancreatic Cancer Drug Shows Late‑Stage Success
SocialApr 13, 2026

Revolution Medicines' Pancreatic Cancer Drug Shows Late‑Stage Success

This is big. All cancers suck. Pancreatic somehow manages to suck even more. Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial https://t.co/rFVsvi0mQD

By Dan Primack
Comprehensive Genomic Landscape of Small Bowel Adenocarcinoma Revealed
SocialApr 13, 2026

Comprehensive Genomic Landscape of Small Bowel Adenocarcinoma Revealed

Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databases [May 14, 2024] Aparicio et al. @BrJCancer https://t.co/xfznlhD4fh #sbcsm #cagenome HT @OncoThor

By Mike Thompson, MD PhD
Multiplexed In‑Vivo Screening Drives Next‑Gen Drug Development
SocialApr 13, 2026

Multiplexed In‑Vivo Screening Drives Next‑Gen Drug Development

Multiplexed in vivo screening is the future of drug development. @ManifoldBio is multiplexing protein therapies in vivo. @GordianBio is multiplexing gene therapies in vivo. @waypointbio is multiplexing cell therapies in vivo. GT Bio is multiplexing LNPs in vivo. 50Y portcos all https://t.co/DT2AwXbKtB

By Seth Bannon